Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
Kenneth Hsu, Shiloh Middlemiss, Federica Saletta, Stephen Gottschalk, Geoffrey McCowage, Belinda Kramer
Topics & Concepts
Chimeric antigen receptorMedicineEPH receptor A2Cancer researchImmunotherapyAntigenImmune systemIn vivoOsteosarcomaImmunologyReceptor tyrosine kinaseReceptorBiologyInternal medicineBiotechnologyCAR-T cell therapy researchImmunotherapy and Immune ResponsesNeuroblastoma Research and Treatments